Category: Diagnostics
Global Diagnostics
-
Clinical Diagnostics Automation
... at a CAGR of 6.5% over the analysis period 2024-2030. The U.S. Market is Estimated at US$1.5 Billion While China is Forecast to Grow at 10.6% CAGR The Clinical Diagnostics Automation market in the U.S. ... Read More
-
Digital Radiography
... CAGR of 5.9% over the analysis period 2024-2030. Computed Radiography (CR), one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$17.0 Billion by the end of the ... Read More
-
Bone Densitometers
... CAGR of 5.6% over the analysis period 2024-2030. Axial Bone Densitometers, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$264.5 Million by the end of the ... Read More
-
Electrophoresis Equipment and Supplies
... 2030, growing at a CAGR of 3.0% over the analysis period 2024-2030. Gel Electrophoresis Systems, one of the segments analyzed in the report, is expected to record a 2.7% CAGR and reach US$1.2 Billion by ... Read More
-
Titrators (Automatic and Manual)
... 2030, growing at a CAGR of 5.3% over the analysis period 2024-2030. Coulometric, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$334.3 Million by the end ... Read More
-
Energy based Ablation Devices
... 2030, growing at a CAGR of 11.4% over the analysis period 2024-2030. Radiation, one of the segments analyzed in the report, is expected to record a 10.5% CAGR and reach US$6.0 Billion by the end ... Read More
-
Intravascular Ultrasound (IVUS)
... at a CAGR of 7.7% over the analysis period 2024-2030. IVUS Catheters, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$659.0 Million by the end of ... Read More
-
Commercial Biotechnology Separation Systems
... 2030, growing at a CAGR of 2.9% over the analysis period 2024-2030. Conventional, one of the segments analyzed in the report, is expected to record a 2.6% CAGR and reach US$19.0 Billion by the end ... Read More
-
ADME-Toxicology Testing
... CAGR of 11.2% over the analysis period 2024-2030. Cell Culture, one of the segments analyzed in the report, is expected to record a 13.2% CAGR and reach US$9.6 Billion by the end of the analysis ... Read More
-
Human Reproductive Technologies
... at a CAGR of 2.2% over the analysis period 2024-2030. Contraceptive Drugs & Devices, one of the segments analyzed in the report, is expected to record a 2.5% CAGR and reach US$22.0 Billion by the ... Read More
-
Histology and Cytology
... at a CAGR of 14.4% over the analysis period 2024-2030. Cytology, one of the segments analyzed in the report, is expected to record a 15.3% CAGR and reach US$50.6 Billion by the end of the ... Read More
-
Immunohematology Analyzers and Reagents
... 2030, growing at a CAGR of 4.7% over the analysis period 2024-2030. Immunohematology Reagents, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$2.3 Billion by the ... Read More
-
In-Vitro Diagnostics (IVD) Packaging
... 2030, growing at a CAGR of 4.5% over the analysis period 2024-2030. Bottles, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$4.0 Billion by the end ... Read More
-
Multiplex Assays
... CAGR of 6.4% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$3.7 Billion by the end of the analysis period. ... Read More
-
Nucleic Acid Isolation and Purification
... Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2024-2030. Kits, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$5.3 Billion by ... Read More
-
Plasma Fractionation
... CAGR of 5.1% over the analysis period 2024-2030. Immunoglobulins, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$14.8 Billion by the end of the analysis period. ... Read More
-
Pneumonia Testing
... CAGR of 6.2% over the analysis period 2024-2030. Immunodiagnostics, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$339.9 Million by the end of the analysis period. ... Read More
-
Point-of-Care/Rapid Diagnostics
... CAGR of 7.5% over the analysis period 2024-2030. Other POC Products, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$3.3 Billion by the end of the ... Read More
-
Positive Material Identification
... at a CAGR of 6.5% over the analysis period 2024-2030. Equipment, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$3.2 Billion by the end of the ... Read More
-
Microfluidics
... 16.0% over the analysis period 2024-2030. Devices, one of the segments analyzed in the report, is expected to record a 14.4% CAGR and reach US$63.5 Billion by the end of the analysis period. Growth in ... Read More
-
MRI Systems
... CAGR of 5.9% over the analysis period 2024-2030. Closed, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$7.6 Billion by the end of the analysis period. ... Read More
-
Paper Diagnostics
... CAGR of 6.6% over the analysis period 2024-2030. Lateral Flow Assay Kits, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$6.7 Billion by the end of ... Read More
-
PET-CT Scanners
... CAGR of 5.0% over the analysis period 2024-2030. Stationary, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$1.6 Billion by the end of the analysis period. ... Read More
-
Poultry Diagnostics
... CAGR of 9.0% over the analysis period 2024-2030. ELISA, one of the segments analyzed in the report, is expected to record a 9.9% CAGR and reach US$558.3 Million by the end of the analysis period. ... Read More
-
Breast Imaging Technologies
... at a CAGR of 5.2% over the analysis period 2024-2030. Ionizing Technologies, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$3.3 Billion by the end of ... Read More